Advertisement
 

doctorslounge.com

 
Powered by
Careerbuilder

 

                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS

   Newsletter

   Oncology

   News

 

 Conferences


   CME

   Forum Archives

   Diseases

   Symptoms

   Labs

   Procedures

   Drugs

   Links
   Specialties

   Cardiology

   Dermatology

   Endocrinology

   Fertility

   Gastroenterology

   Gynecology

   Hematology

   Infections

   Nephrology

   Neurology

   Oncology

   Orthopedics

   Pediatrics

   Pharmacy

   Primary Care

   Psychiatry

   Pulmonology

   Rheumatology

   Surgery

   Urology

   Other Sections

   Membership

   Research Tools

   Medical Tutorials

   Medical Software

 

 Headlines:

 
 

Back to cancer staging index

Cancer Staging Systems

Staging of cervical cancer

Last Update: Sunday January 4th, 2004 7:15 PM GMT

TNM definition

Primary tumor (T)

  • TX: Primary tumor cannot be assessed
  • T0: No evidence of primary tumor
  • Tis: Carcinoma in situ
  • T1/I: Cervical carcinoma confined to uterus (extension to corpus should be disregarded)
    • T1a/IA: Invasive carcinoma diagnosed only by microscopy. All macroscopically visible lesions--even with superficial invasion--are T1b/IB. Stromal invasion with a maximal depth of 5 mm measured from the base of the epithelium and a horizontal spread of 7 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification
    • T1a1/Ia1: Measured stromal invasion 3 mm or less in depth and 7 mm or less in horizontal spread
    • T1a2/IA2: Measured stromal invasion more than 3 mm and not more than 5 mm with a horizontal spread 7 mm or less
    • T1b/IB: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2
    • T1b1/IB1: Clinically visible lesion 4 cm or less in greatest dimension
    • T1b2/IB2: Clinically visible lesion more than 4 cm in greatest dimension
  • T2/II: Cervical carcinoma invades beyond uterus but not to pelvic wall or to the lower third of the vagina
    • T2a/IIa: Tumor without parametrial involvement
    • T2b/IIb: Tumor with parametrial involvement
  • T3/III: Tumor extends to the pelvic wall and/or involves the lower third of the vagina, and/or causes hydronephrosis or nonfunctioning kidney
    • T3a/IIIA: Tumor involves lower third of the vagina, no extension to pelvic wall
    • T3b/IIIB: Tumor extends to pelvic wall and/or causes hydronephrosis or nonfunctioning kidney
  • T4/IVA: Tumor invades mucosa of the bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4)
    • M1/IVB: Distant metastasis

Regional lymph nodes (N)

  • NX: Regional lymph nodes cannot be assessed
  • N0: No regional lymph node metastasis
  • N1: Regional lymph node metastasis

Distant metastasis (M)

  • MX: Distant metastasis cannot be assessed
  • M0: No distant metastasis
  • M1: Distant metastasis
advertisement.gif (61x7 -- 0 bytes)
 

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application


Stage grouping

Stage 0

  • Tis, N0, M0

Stage 0 is carcinoma in situ, intraepithelial carcinoma. There is no stromal invasion.

Stage IA1

  • T1a1, N0, M0

Stage IA2

  • T1a2, N0, M0

Stage IB1

  • T1b1, N0, M0

Stage IB2

  • T1b2, N0, M0

Stage IIA

  • T2a, N0, M0

Stage IIB

T2b, N0, M0

Stage IIIA

  • T3a, N0, M0

Stage IIIB

  • T1, N1, M0
  • T2, N1, M0
  • T3a, N1, M0
  • T3b, any N, M0

Stage IVA

  • T4, any N, M0

Stage IVB

  • Any T, any N, M1

FIGO staging

Stage I

Stage I is carcinoma strictly confined to the cervix; extension to the uterine corpus should be disregarded.

  • Stage IA: Invasive cancer identified only microscopically. All gross lesions even with superficial invasion are stage Ib cancers. Invasion is limited to measured stromal invasion with a maximum depth of 5 mm* and no wider than 7 mm. [Note: *The depth of invasion should not be more than 5 mm taken from the base of the epithelium, either surface or glandular, from which it originates. Vascular space involvement, either venous or lymphatic, should not alter the staging.]
    • Stage IA1: Measured invasion of the stroma no greater than 3 mm in depth and no wider than 7 mm diameter.
    • Stage IA2: Measured invasion of stroma greater than 3 mm but no greater than 5 mm in depth and no wider than 7 mm in diameter.
  • Stage IB: Clinical lesions confined to the cervix or preclinical lesions greater than stage IA.
    • Stage IB1: Clinical lesions no greater than 4 cm in size.
    • Stage IB2: Clinical lesions greater than 4 cm in size.

Stage II

Stage II is carcinoma that extends beyond the cervix but has not extended onto the pelvic wall. The carcinoma involves the vagina, but not as far as the lower third.

  • Stage IIA: No obvious parametrial involvement. Involvement of up to the upper two thirds of the vagina.
  • Stage IIB: Obvious parametrial involvement, but not onto the pelvic sidewall.

Stage III

Stage III is carcinoma that has extended onto the pelvic sidewall. On rectal examination, there is no cancer-free space between the tumor and the pelvic sidewall. The tumor involves the lower third of the vagina. All cases with a hydronephrosis or nonfunctioning kidney should be included, unless they are known to be due to other causes.

  • Stage IIIA: No extension onto the pelvic sidewall but involvement of the lower third of the vagina.
  • Stage IIIB: Extension onto the pelvic sidewall or hydronephrosis or nonfunctioning kidney.

Stage IV

Stage IV is carcinoma that has extended beyond the true pelvis or has clinically involved the mucosa of the bladder and/or rectum.

  • Stage IVA: Spread of the tumor onto adjacent pelvic organs.
  • Stage IVB: Spread to distant organs.

References

  1. Shepherd JH: Cervical and vulva cancer: changes in FIGO definitions of staging. Br J Obstet Gynaecol 103 (5): 405-6, 1996.
  2. Creasman WT: New gynecologic cancer staging. Gynecol Oncol 58 (2): 157-8, 1995.
  3. Cervix uteri. In: American Joint Committee on Cancer.: AJCC Cancer Staging Manual. 5th ed. Philadelphia, Pa: Lippincott-Raven Publishers, 1997, pp 189-194.
 

 advertisement.gif (61x7 -- 0 bytes)

 

 



We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright 2001-2012 DoctorsLounge. All rights reserved.